{"doc_id": "si-2021-0492-reg-1", "parent_doc_id": "si-2021-0492", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 492 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 9) Regulations 2021. \n\n(2) The collective citation “the Medicinal Products (Prescription and Control \n\nof Supply) Regulations 2003 to 2021” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 9) regulation 2021 (2) collective citation medicinal product (prescription control supply) regulation 2003 2021 includes regulation", "start_char": 640, "end_char": 930, "source_path": "downloads\\2021\\2021_0492.pdf", "extraction_method": "pdfminer", "checksum": "sha256:e6f040d4dc28390ae5556b3cfe9ed025cc3cd9ce4c433d628e47b5068e8b38ae", "cross_refs": []}
{"doc_id": "si-2021-0492-reg-2", "parent_doc_id": "si-2021-0492", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 492 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and Control \nof Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations of 2021” means the Medicinal Products (Prescription and Control \nof Supply) (Amendment) (No. 8) Regulations 2021 (S.I. No. 411 of 2021).", "text_norm": "2 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation 2021 mean medicinal product (prescription control supply) (amendment) (no 8) regulation 2021 (s.i no 411 2021)", "start_char": 930, "end_char": 1245, "source_path": "downloads\\2021\\2021_0492.pdf", "extraction_method": "pdfminer", "checksum": "sha256:e6f040d4dc28390ae5556b3cfe9ed025cc3cd9ce4c433d628e47b5068e8b38ae", "cross_refs": []}
{"doc_id": "si-2021-0492-reg-3", "parent_doc_id": "si-2021-0492", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 492 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "3. The Eighth Schedule (as amended by Regulations 3 and 5 of the", "text_raw": "3. The Eighth Schedule (as amended by Regulations 3 and 5 of the \n\nRegulations of 2021) to the Principal Regulations is amended— \n\n(a) \n\n(b) \n\nin Column 3 of the entry for the medicinal product “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA \nVaccine (nucleoside modified)”, by deleting “as a course of 2 \ndoses (0.3 ml each) at least 21 days apart”, and \n\nin Column 5 of the entries for the medicinal products “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA \nVaccine (nucleoside modified)” and “COVID-19 Vaccine \nModerna dispersion for injection COVID-19 mRNA Vaccine \n(nucleoside modified)”, by inserting the following additional text: \n\n“Notwithstanding any guidance to the contrary in the summary of \nproduct characteristics— \n\n(a) \n\nan additional dose may be administered to a person who has \nalready received a primary vaccine course listed in this \nSchedule where— \n\n(i) \n\nthe person is 12 years of age or older, \n\n(ii) \n\nthe person is immunocompromised, \n\n(iii) 2 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 1st October, 2021. \n\n \n \n \n \n \n \n \n\f[492] 3 \n\n(iv) \n\ninformed consent is obtained from the person (or, in \nthe case of a person between 12 and 15 years of age, \nfrom his or her legal guardian), and \n\n(b) \n\na booster or subsequent dose may be administered to a \nperson who has already received a primary vaccine course \nlisted in this Schedule where— \n\n(i) \n\nthe person is— \n\n(I) \n\n65 years of age or older and a resident of a longterm care facility, or \n\n(II) 80 years of age or older, \n\n(ii) 6 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\n(iii) \n\ninformed consent is obtained.”.", "text_norm": "3 eighth schedule (as amended regulation 3 5 regulation 2021) principal regulation amended-- (a) (b) column 3 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) deleting course 2 dos (0.3 ml each) least 21 day apart column 5 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) covid-19 vaccine moderna dispersion injection covid-19 mrna vaccine (nucleoside modified) inserting following additional text notwithstanding guidance contrary summary product characteristics-- (a) additional dose may administered person already received primary vaccine course listed schedule where-- (i) person 12 year age older (ii) person immunocompromised (iii) 2 month passed since administration said primary vaccine course notice making statutory instrument published iris oifigiuil 1st october 2021 492 3 (iv) informed consent obtained person (or case person 12 15 year age legal guardian) (b) booster subsequent dose may administered person already received primary vaccine course listed schedule where-- (i) person is-- (i) 65 year age older resident longterm care facility (ii) 80 year age older (ii) 6 month passed since administration said primary vaccine course (iii) informed consent obtained", "start_char": 1245, "end_char": 3076, "source_path": "downloads\\2021\\2021_0492.pdf", "extraction_method": "pdfminer", "checksum": "sha256:e6f040d4dc28390ae5556b3cfe9ed025cc3cd9ce4c433d628e47b5068e8b38ae", "cross_refs": []}
{"doc_id": "si-2021-0492-reg-4", "parent_doc_id": "si-2021-0492", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 492 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "4. The Twelfth Schedule (as amended by Regulations 4 and 6 of the", "text_raw": "4. The Twelfth Schedule (as amended by Regulations 4 and 6 of the \n\nRegulations of 2021) to the Principal Regulations is amended— \n\n(a) \n\n(b) \n\nin Column 3 of the entry for the medicinal product “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA \nVaccine (nucleoside modified)”, by deleting “as a course of 2 \ndoses (0.3 ml each) at least 21 days apart”, and \n\nin Column 5 of the entries for the medicinal products “Comirnaty \nconcentrate for dispersion for injection COVID-19 mRNA \nVaccine (nucleoside modified)” and “COVID-19 Vaccine \nModerna dispersion for injection COVID-19 mRNA Vaccine \n(nucleoside modified)”, by inserting the following additional text: \n\n“Notwithstanding any guidance to the contrary in the summary of \nproduct characteristics— \n\n(a) \n\nan additional dose may be administered to a person who has \nalready received a primary vaccine course listed in this \nSchedule where— \n\n(i) \n\nthe person is 12 years of age or older, \n\n(ii) \n\nthe person is immunocompromised, \n\n(iii) 2 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\n(iv) \n\ninformed consent is obtained from the person (or, in \nthe case of a person between 12 and 15 years of age, \nfrom his or her legal guardian), and \n\n(b) \n\na booster or subsequent dose may be administered to a \nperson who has already received a primary vaccine course \nlisted in this Schedule where— \n\n \n \n\f4 [492] \n\n(i) \n\nthe person is— \n\n(I) \n\n65 years of age or older and a resident of a longterm care facility, or \n\n(II) 80 years of age or older, \n\n(ii) 6 months or more have passed since \n\nthe \nadministration of the said primary vaccine course, \nand \n\n(iii) \n\ninformed consent is obtained.”. \n\nGIVEN under my Official Seal, \n\n28 September, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n\f[492] 5", "text_norm": "4 twelfth schedule (as amended regulation 4 6 regulation 2021) principal regulation amended-- (a) (b) column 3 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) deleting course 2 dos (0.3 ml each) least 21 day apart column 5 entry medicinal product comirnaty concentrate dispersion injection covid-19 mrna vaccine (nucleoside modified) covid-19 vaccine moderna dispersion injection covid-19 mrna vaccine (nucleoside modified) inserting following additional text notwithstanding guidance contrary summary product characteristics-- (a) additional dose may administered person already received primary vaccine course listed schedule where-- (i) person 12 year age older (ii) person immunocompromised (iii) 2 month passed since administration said primary vaccine course (iv) informed consent obtained person (or case person 12 15 year age legal guardian) (b) booster subsequent dose may administered person already received primary vaccine course listed schedule where-- 4 492 (i) person is-- (i) 65 year age older resident longterm care facility (ii) 80 year age older (ii) 6 month passed since administration said primary vaccine course (iii) informed consent obtained  given official seal 28 september 2021 stephen donnelly minister health 492 5", "start_char": 3076, "end_char": 4918, "source_path": "downloads\\2021\\2021_0492.pdf", "extraction_method": "pdfminer", "checksum": "sha256:e6f040d4dc28390ae5556b3cfe9ed025cc3cd9ce4c433d628e47b5068e8b38ae", "cross_refs": []}
{"doc_id": "si-2021-0492-explanatory-note", "parent_doc_id": "si-2021-0492", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 492 of 2021", "title": "“Principal Regulations” means the Medicinal Products (Prescription and Control", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to allow for additional or booster/subsequent \ndoses of mRNA COVID-19 vaccines to be supplied and administered to certain \npersons. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 9) Regulations 2021. \n\n \n \n \n \n \n \n \n \n\f6 [492] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€3.00 \n\n(DH-297) 75. 9/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation allow additional booster subsequent dos mrna covid-19 vaccine supplied administered certain person regulation may cited medicinal product (prescription control supply) (amendment) (no 9) regulation 2021 6 492 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur3.00 (dh-297) 75 9 21 propylon", "start_char": 4918, "end_char": 5952, "source_path": "downloads\\2021\\2021_0492.pdf", "extraction_method": "pdfminer", "checksum": "sha256:e6f040d4dc28390ae5556b3cfe9ed025cc3cd9ce4c433d628e47b5068e8b38ae", "cross_refs": []}
